Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neuroblastoma × XK 469 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroblastoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Erythroblastic, Acute 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1 Congenital Abnormalities 1 Blast Crisis 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 45 Etoposide 31 Filgrastim 27 Carboplatin 25 Doxorubicin 24 Vincristine 22 Melphalan 22 Isotretinoin 22 Topotecan 21 Granulocyte Colony-Stimulating Factor 19 Irinotecan 18 Peripheral Blood Stem Cell Transplantation 17 Cisplatin 16 sargramostim 15 Temozolomide 15 3-Iodobenzylguanidine 13 humanized 3F8 anti-GD2 monoclonal antibody 12 Radiotherapy 11 Granulocyte-Macrophage Colony-Stimulating Factor 10 dinutuximab 8 Busulfan 8 Interleukin-2 7 etoposide phosphate 6 aldesleukin 6 Stem Cell Transplantation 6 Polymerase Chain Reaction 6 Vorinostat 5 Thiotepa 5 Methylprednisolone 5 Ifosfamide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00028522 2013-12-16

R(+)XK469 in Treating Patients With Advanced Neuroblastoma

National Cancer Institute (NCI)

Phase 1 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡